NVCT
Nuvectis Pharma Inc
20.00$
-6.4%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | -9,100.0% | – | – | – | |
| – | – | 1,145.6% | – | – | – | |
| – | – | 1,145.6% | – | – | – | |
| – | – | 2,563.1% | – | – | – | |
| – | – | 0.0% | – | – | – | |
| – | – | 18,664.4% | – | – | – | |
| – | – | 18,664.4% | – | – | – | |
| – | – | 9,564.4% | – | – | – | |
| – | – | -9,100.0% | – | – | – |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.